Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Baxter
McKinsey
QuintilesIMS
Argus Health
Cerilliant
Chubb
Deloitte

Generated: April 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: METHENAMINE HIPPURATE

« Back to Dashboard

METHENAMINE HIPPURATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681 NDA Sanofi-Aventis U.S. LLC E 0068-0277-61
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681 NDA Winthrop U.S. E 0955-1037-10
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681 NDA Validus Pharmaceuticals LLC N 30698-277-01
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681 NDA AUTHORIZED GENERIC Leading Pharma, LLC N 69315-210-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Baxter
Harvard Business School
Julphar
US Department of Justice
UBS
Moodys
Johnson and Johnson